{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:36:37Z","timestamp":1793316997472,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K76AG088428"],"award-info":[{"award-number":["K76AG088428"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031147","name":"Duke Claude D. Pepper Older Americans Independence Center, Duke Aging Center, Duke University","doi-asserted-by":"publisher","award":["P30AG021342"],"award-info":[{"award-number":["P30AG021342"]}],"id":[{"id":"10.13039\/100031147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.amjcard.2025.04.025","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T19:14:17Z","timestamp":1745435657000},"page":"59-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["CHA2DS2-VASc Score in Patients With Atrial Fibrillation and Cancer: A U.S. Nationwide Study"],"prefix":"10.1016","volume":"249","author":[{"given":"Mohammad","family":"AL Mouslmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Alhoda","family":"Alahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Akman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiza","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufti","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-1636","authenticated-orcid":false,"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjcard.2025.04.025_bib0001","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaccao.2023.01.007","article-title":"CHA2DS2-VASc Score in Cardio-Oncology","volume":"5","author":"L\u00f3pez-Fern\u00e1ndez","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"41","key":"10.1016\/j.amjcard.2025.04.025_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"European heart journal"},{"issue":"2","key":"10.1016\/j.amjcard.2025.04.025_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijcard.2012.08.036","article-title":"Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients","volume":"165","author":"Hu","year":"2013","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.amjcard.2025.04.025_bib0004","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00277-018-3346-1","article-title":"Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma","volume":"97","author":"Sorigue","year":"2018","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.amjcard.2025.04.025_bib0005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JOP.18.00592","article-title":"Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists","volume":"15","author":"Sorigue","year":"2019","journal-title":"J Oncol Pract"},{"issue":"25","key":"10.1016\/j.amjcard.2025.04.025_bib0006","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/eurheartj\/ehae222","article-title":"Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study","volume":"45","author":"Chen","year":"2024","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1016\/j.amjcard.2025.04.025_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2016.0280","article-title":"Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation","volume":"1","author":"Conen","year":"2016","journal-title":"JAMA cardiology"},{"issue":"7","key":"10.1016\/j.amjcard.2025.04.025_bib0008","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9343(02)01029-X","article-title":"Colorectal cancer and atrial fibrillation: a case-control study","volume":"112","author":"Guzzetti","year":"2002","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.amjcard.2025.04.025_bib0009","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11739-011-0701-9","article-title":"Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case-control study","volume":"7","author":"Erichsen","year":"2012","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.amjcard.2025.04.025_bib0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamacardio.2016.0582","article-title":"Association of Atrial Fibrillation and Cancer","volume":"1","author":"Rahman","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.amjcard.2025.04.025_bib0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaccao.2021.03.006","article-title":"Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study","volume":"3","author":"Yun","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.amjcard.2025.04.025_bib0012","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.amjcard.2025.04.025_bib0013","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.amjcard.2025.04.025_bib0014","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/eurjpc\/zwaa054","article-title":"Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management","volume":"28","author":"Boriani","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.amjcard.2025.04.025_bib0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaccao.2022.08.014","article-title":"Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer","volume":"5","author":"Leader","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"10","key":"10.1016\/j.amjcard.2025.04.025_bib0016","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.amjcard.2025.04.025_bib0017","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4070\/kcj.2017.0328","article-title":"Joung B. Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer","volume":"48","author":"Kim","year":"2018","journal-title":"Korean Circ J"},{"key":"10.1016\/j.amjcard.2025.04.025_bib0018","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijcard.2015.10.166","article-title":"Joung B. Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy","volume":"203","author":"Lee","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2025.04.025_bib0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.thromres.2016.05.028","article-title":"The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism","volume":"144","author":"Ambrus","year":"2016","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.amjcard.2025.04.025_bib0020","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.amjcard.2017.08.038","article-title":"Usefulness of CHADS2 and CHA2DS2-VASc Scores for Stroke Prediction in Patients With Cancer and Atrial Fibrillation","volume":"120","author":"Patell","year":"2017","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.amjcard.2025.04.025_bib0021","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/2047487318759858","article-title":"CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer","volume":"25","author":"D'Souza","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"10.1016\/j.amjcard.2025.04.025_bib0022","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/cncr.33470","article-title":"Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study","volume":"127","author":"Pastori","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.amjcard.2025.04.025_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjcard.2022.06.044","article-title":"Validation of Embolic and Bleeding Risk Scores in Patients With Atrial Fibrillation and Cancer","volume":"180","author":"Raposeiras-Roubin","year":"2022","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1016\/j.amjcard.2025.04.025_bib0024","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11739-022-03156-w","article-title":"Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis","volume":"18","author":"Pastori","year":"2023","journal-title":"Intern Emerg Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925002802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925002802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T15:56:35Z","timestamp":1749743795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925002802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"alternative-id":["S0002914925002802"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.04.025","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CHA2DS2-VASc Score in Patients With Atrial Fibrillation and Cancer: A U.S. Nationwide Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}